title: Toxic effects of adriamycin on the central nervous system. Ultrastructural changes in some circumventricular organs of the mouse after intravenous administration of the drug.
abstract: Recent experimental studies have shown that the cytotoxic antibiotic adriamycin (doxorubicin) after systemic administration can enter the so-called circumventricular organs (CVO) of the brain of the mouse. The present experiments were performed to find out whether such penetration of the brain is associated with signs of neurotoxic injury. For this purpose, light- and electron-microscopic observations were carried out on three of these organs: the neurohypophysis (NH), median eminence (ME), and postremal area (PA). Pronounced widening of the extracellular space indicating the presence of edema was present in all the regions, particularly in animals examined within 3 days of injection of the drug. Many degenerated axon terminals were observed in the NH and ME. The glial cells within these regions showed rarefaction of the nuclear chromatin, nucleolar segregation, and also cytoplasmic changes. The PA presented marked cellular changes resulting in degeneration of neurons, which was most evident 30 days after the injection. Hence, regions of the CNS outside the blood-brain barrier can be reached by adriamycin after systemic administration, and the drug can induce morphological changes there. The doses of the drug used in the present experiments were comparable to those given to patients for the treatment of malignant tumors.
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier; D001933:Brain Stem / Q000648:ultrastructure; D002490:Central Nervous System / Q000187:drug effects*; D004317:Doxorubicin / Q000633:toxicity*; D005110:Extracellular Space / Q000648:ultrastructure; D008297:Male; D008473:Median Eminence / Q000648:ultrastructure; D051379:Mice; D008854:Microscopy, Electron; D009457:Neuroglia / Q000648:ultrastructure; D010904:Pituitary Gland, Posterior / Q000648:ultrastructure; D013997:Time Factors
chemical_list: D004317:Doxorubicin